Global Inhaled Nasal Influenza Vaccine Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Inhaled Nasal Influenza Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Inhaled Nasal Influenza Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Inhaled Nasal Influenza Vaccine by Country/Region, 2017, 2022 & 2028

2.2 Inhaled Nasal Influenza Vaccine Segment by Type

2.2.1 Live Attenuated Influenza Vaccine

2.2.2 Split Influenza Vaccine

2.3 Inhaled Nasal Influenza Vaccine Sales by Type

2.3.1 Global Inhaled Nasal Influenza Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global Inhaled Nasal Influenza Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Inhaled Nasal Influenza Vaccine Sale Price by Type (2017-2022)

2.4 Inhaled Nasal Influenza Vaccine Segment by Application

2.4.1 3-17 Years

2.4.2 Others

2.5 Inhaled Nasal Influenza Vaccine Sales by Application

2.5.1 Global Inhaled Nasal Influenza Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global Inhaled Nasal Influenza Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Inhaled Nasal Influenza Vaccine Sale Price by Application (2017-2022)

3 Global Inhaled Nasal Influenza Vaccine by Company

3.1 Global Inhaled Nasal Influenza Vaccine Breakdown Data by Company

3.1.1 Global Inhaled Nasal Influenza Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global Inhaled Nasal Influenza Vaccine Sales Market Share by Company (2020-2022)

3.2 Global Inhaled Nasal Influenza Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global Inhaled Nasal Influenza Vaccine Revenue by Company (2020-2022)

3.2.2 Global Inhaled Nasal Influenza Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global Inhaled Nasal Influenza Vaccine Sale Price by Company

3.4 Key Manufacturers Inhaled Nasal Influenza Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Inhaled Nasal Influenza Vaccine Product Location Distribution

3.4.2 Players Inhaled Nasal Influenza Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Inhaled Nasal Influenza Vaccine by Geographic Region

4.1 World Historic Inhaled Nasal Influenza Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global Inhaled Nasal Influenza Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Inhaled Nasal Influenza Vaccine Annual Revenue by Geographic Region

4.2 World Historic Inhaled Nasal Influenza Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global Inhaled Nasal Influenza Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Inhaled Nasal Influenza Vaccine Annual Revenue by Country/Region

4.3 Americas Inhaled Nasal Influenza Vaccine Sales Growth

4.4 APAC Inhaled Nasal Influenza Vaccine Sales Growth

4.5 Europe Inhaled Nasal Influenza Vaccine Sales Growth

4.6 Middle East & Africa Inhaled Nasal Influenza Vaccine Sales Growth

5 Americas

5.1 Americas Inhaled Nasal Influenza Vaccine Sales by Country

5.1.1 Americas Inhaled Nasal Influenza Vaccine Sales by Country (2017-2022)

5.1.2 Americas Inhaled Nasal Influenza Vaccine Revenue by Country (2017-2022)

5.2 Americas Inhaled Nasal Influenza Vaccine Sales by Type

5.3 Americas Inhaled Nasal Influenza Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Inhaled Nasal Influenza Vaccine Sales by Region

6.1.1 APAC Inhaled Nasal Influenza Vaccine Sales by Region (2017-2022)

6.1.2 APAC Inhaled Nasal Influenza Vaccine Revenue by Region (2017-2022)

6.2 APAC Inhaled Nasal Influenza Vaccine Sales by Type

6.3 APAC Inhaled Nasal Influenza Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Inhaled Nasal Influenza Vaccine by Country

7.1.1 Europe Inhaled Nasal Influenza Vaccine Sales by Country (2017-2022)

7.1.2 Europe Inhaled Nasal Influenza Vaccine Revenue by Country (2017-2022)

7.2 Europe Inhaled Nasal Influenza Vaccine Sales by Type

7.3 Europe Inhaled Nasal Influenza Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Inhaled Nasal Influenza Vaccine by Country

8.1.1 Middle East & Africa Inhaled Nasal Influenza Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Inhaled Nasal Influenza Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa Inhaled Nasal Influenza Vaccine Sales by Type

8.3 Middle East & Africa Inhaled Nasal Influenza Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Inhaled Nasal Influenza Vaccine

10.3 Manufacturing Process Analysis of Inhaled Nasal Influenza Vaccine

10.4 Industry Chain Structure of Inhaled Nasal Influenza Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Inhaled Nasal Influenza Vaccine Distributors

11.3 Inhaled Nasal Influenza Vaccine Customer

12 World Forecast Review for Inhaled Nasal Influenza Vaccine by Geographic Region

12.1 Global Inhaled Nasal Influenza Vaccine Market Size Forecast by Region

12.1.1 Global Inhaled Nasal Influenza Vaccine Forecast by Region (2023-2028)

12.1.2 Global Inhaled Nasal Influenza Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Inhaled Nasal Influenza Vaccine Forecast by Type

12.7 Global Inhaled Nasal Influenza Vaccine Forecast by Application

13 Key Players Analysis

13.1 AstraZeneca

13.1.1 AstraZeneca Company Information

13.1.2 AstraZeneca Inhaled Nasal Influenza Vaccine Product Offered

13.1.3 AstraZeneca Inhaled Nasal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 AstraZeneca Main Business Overview

13.1.5 AstraZeneca Latest Developments

13.2 Cipla

13.2.1 Cipla Company Information

13.2.2 Cipla Inhaled Nasal Influenza Vaccine Product Offered

13.2.3 Cipla Inhaled Nasal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Cipla Main Business Overview

13.2.5 Cipla Latest Developments

13.3 BCHT

13.3.1 BCHT Company Information

13.3.2 BCHT Inhaled Nasal Influenza Vaccine Product Offered

13.3.3 BCHT Inhaled Nasal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 BCHT Main Business Overview

13.3.5 BCHT Latest Developments

14 Research Findings and Conclusion

Table 1. Inhaled Nasal Influenza Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Inhaled Nasal Influenza Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Live Attenuated Influenza Vaccine

Table 4. Major Players of Split Influenza Vaccine

Table 5. Global Inhaled Nasal Influenza Vaccine Sales by Type (2017-2022) & (K Dose)

Table 6. Global Inhaled Nasal Influenza Vaccine Sales Market Share by Type (2017-2022)

Table 7. Global Inhaled Nasal Influenza Vaccine Revenue by Type (2017-2022) & ($ million)

Table 8. Global Inhaled Nasal Influenza Vaccine Revenue Market Share by Type (2017-2022)

Table 9. Global Inhaled Nasal Influenza Vaccine Sale Price by Type (2017-2022) & (US$/Dose)

Table 10. Global Inhaled Nasal Influenza Vaccine Sales by Application (2017-2022) & (K Dose)

Table 11. Global Inhaled Nasal Influenza Vaccine Sales Market Share by Application (2017-2022)

Table 12. Global Inhaled Nasal Influenza Vaccine Revenue by Application (2017-2022)

Table 13. Global Inhaled Nasal Influenza Vaccine Revenue Market Share by Application (2017-2022)

Table 14. Global Inhaled Nasal Influenza Vaccine Sale Price by Application (2017-2022) & (US$/Dose)

Table 15. Global Inhaled Nasal Influenza Vaccine Sales by Company (2020-2022) & (K Dose)

Table 16. Global Inhaled Nasal Influenza Vaccine Sales Market Share by Company (2020-2022)

Table 17. Global Inhaled Nasal Influenza Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Inhaled Nasal Influenza Vaccine Revenue Market Share by Company (2020-2022)

Table 19. Global Inhaled Nasal Influenza Vaccine Sale Price by Company (2020-2022) & (US$/Dose)

Table 20. Key Manufacturers Inhaled Nasal Influenza Vaccine Producing Area Distribution and Sales Area

Table 21. Players Inhaled Nasal Influenza Vaccine Products Offered

Table 22. Inhaled Nasal Influenza Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Inhaled Nasal Influenza Vaccine Sales by Geographic Region (2017-2022) & (K Dose)

Table 26. Global Inhaled Nasal Influenza Vaccine Sales Market Share Geographic Region (2017-2022)

Table 27. Global Inhaled Nasal Influenza Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Inhaled Nasal Influenza Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Inhaled Nasal Influenza Vaccine Sales by Country/Region (2017-2022) & (K Dose)

Table 30. Global Inhaled Nasal Influenza Vaccine Sales Market Share by Country/Region (2017-2022)

Table 31. Global Inhaled Nasal Influenza Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Inhaled Nasal Influenza Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Inhaled Nasal Influenza Vaccine Sales by Country (2017-2022) & (K Dose)

Table 34. Americas Inhaled Nasal Influenza Vaccine Sales Market Share by Country (2017-2022)

Table 35. Americas Inhaled Nasal Influenza Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Inhaled Nasal Influenza Vaccine Revenue Market Share by Country (2017-2022)

Table 37. Americas Inhaled Nasal Influenza Vaccine Sales by Type (2017-2022) & (K Dose)

Table 38. Americas Inhaled Nasal Influenza Vaccine Sales Market Share by Type (2017-2022)

Table 39. Americas Inhaled Nasal Influenza Vaccine Sales by Application (2017-2022) & (K Dose)

Table 40. Americas Inhaled Nasal Influenza Vaccine Sales Market Share by Application (2017-2022)

Table 41. APAC Inhaled Nasal Influenza Vaccine Sales by Region (2017-2022) & (K Dose)

Table 42. APAC Inhaled Nasal Influenza Vaccine Sales Market Share by Region (2017-2022)

Table 43. APAC Inhaled Nasal Influenza Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Inhaled Nasal Influenza Vaccine Revenue Market Share by Region (2017-2022)

Table 45. APAC Inhaled Nasal Influenza Vaccine Sales by Type (2017-2022) & (K Dose)

Table 46. APAC Inhaled Nasal Influenza Vaccine Sales Market Share by Type (2017-2022)

Table 47. APAC Inhaled Nasal Influenza Vaccine Sales by Application (2017-2022) & (K Dose)

Table 48. APAC Inhaled Nasal Influenza Vaccine Sales Market Share by Application (2017-2022)

Table 49. Europe Inhaled Nasal Influenza Vaccine Sales by Country (2017-2022) & (K Dose)

Table 50. Europe Inhaled Nasal Influenza Vaccine Sales Market Share by Country (2017-2022)

Table 51. Europe Inhaled Nasal Influenza Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Inhaled Nasal Influenza Vaccine Revenue Market Share by Country (2017-2022)

Table 53. Europe Inhaled Nasal Influenza Vaccine Sales by Type (2017-2022) & (K Dose)

Table 54. Europe Inhaled Nasal Influenza Vaccine Sales Market Share by Type (2017-2022)

Table 55. Europe Inhaled Nasal Influenza Vaccine Sales by Application (2017-2022) & (K Dose)

Table 56. Europe Inhaled Nasal Influenza Vaccine Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Inhaled Nasal Influenza Vaccine Sales by Country (2017-2022) & (K Dose)

Table 58. Middle East & Africa Inhaled Nasal Influenza Vaccine Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Inhaled Nasal Influenza Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Inhaled Nasal Influenza Vaccine Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Inhaled Nasal Influenza Vaccine Sales by Type (2017-2022) & (K Dose)

Table 62. Middle East & Africa Inhaled Nasal Influenza Vaccine Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Inhaled Nasal Influenza Vaccine Sales by Application (2017-2022) & (K Dose)

Table 64. Middle East & Africa Inhaled Nasal Influenza Vaccine Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Inhaled Nasal Influenza Vaccine

Table 66. Key Market Challenges & Risks of Inhaled Nasal Influenza Vaccine

Table 67. Key Industry Trends of Inhaled Nasal Influenza Vaccine

Table 68. Inhaled Nasal Influenza Vaccine Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Inhaled Nasal Influenza Vaccine Distributors List

Table 71. Inhaled Nasal Influenza Vaccine Customer List

Table 72. Global Inhaled Nasal Influenza Vaccine Sales Forecast by Region (2023-2028) & (K Dose)

Table 73. Global Inhaled Nasal Influenza Vaccine Sales Market Forecast by Region

Table 74. Global Inhaled Nasal Influenza Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Inhaled Nasal Influenza Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Inhaled Nasal Influenza Vaccine Sales Forecast by Country (2023-2028) & (K Dose)

Table 77. Americas Inhaled Nasal Influenza Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Inhaled Nasal Influenza Vaccine Sales Forecast by Region (2023-2028) & (K Dose)

Table 79. APAC Inhaled Nasal Influenza Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Inhaled Nasal Influenza Vaccine Sales Forecast by Country (2023-2028) & (K Dose)

Table 81. Europe Inhaled Nasal Influenza Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Inhaled Nasal Influenza Vaccine Sales Forecast by Country (2023-2028) & (K Dose)

Table 83. Middle East & Africa Inhaled Nasal Influenza Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Inhaled Nasal Influenza Vaccine Sales Forecast by Type (2023-2028) & (K Dose)

Table 85. Global Inhaled Nasal Influenza Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Inhaled Nasal Influenza Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Inhaled Nasal Influenza Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Inhaled Nasal Influenza Vaccine Sales Forecast by Application (2023-2028) & (K Dose)

Table 89. Global Inhaled Nasal Influenza Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Inhaled Nasal Influenza Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Inhaled Nasal Influenza Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 92. AstraZeneca Basic Information, Inhaled Nasal Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 93. AstraZeneca Inhaled Nasal Influenza Vaccine Product Offered

Table 94. AstraZeneca Inhaled Nasal Influenza Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 95. AstraZeneca Main Business

Table 96. AstraZeneca Latest Developments

Table 97. Cipla Basic Information, Inhaled Nasal Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 98. Cipla Inhaled Nasal Influenza Vaccine Product Offered

Table 99. Cipla Inhaled Nasal Influenza Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 100. Cipla Main Business

Table 101. Cipla Latest Developments

Table 102. BCHT Basic Information, Inhaled Nasal Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 103. BCHT Inhaled Nasal Influenza Vaccine Product Offered

Table 104. BCHT Inhaled Nasal Influenza Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 105. BCHT Main Business

Table 106. BCHT Latest Developments

List of Figures

Figure 1. Picture of Inhaled Nasal Influenza Vaccine

Figure 2. Inhaled Nasal Influenza Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Inhaled Nasal Influenza Vaccine Sales Growth Rate 2017-2028 (K Dose)

Figure 7. Global Inhaled Nasal Influenza Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Inhaled Nasal Influenza Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Live Attenuated Influenza Vaccine

Figure 10. Product Picture of Split Influenza Vaccine

Figure 11. Global Inhaled Nasal Influenza Vaccine Sales Market Share by Type in 2021

Figure 12. Global Inhaled Nasal Influenza Vaccine Revenue Market Share by Type (2017-2022)

Figure 13. Inhaled Nasal Influenza Vaccine Consumed in 3-17 Years

Figure 14. Global Inhaled Nasal Influenza Vaccine Market: 3-17 Years (2017-2022) & (K Dose)

Figure 15. Inhaled Nasal Influenza Vaccine Consumed in Others

Figure 16. Global Inhaled Nasal Influenza Vaccine Market: Others (2017-2022) & (K Dose)

Figure 17. Global Inhaled Nasal Influenza Vaccine Sales Market Share by Application (2017-2022)

Figure 18. Global Inhaled Nasal Influenza Vaccine Revenue Market Share by Application in 2021

Figure 19. Inhaled Nasal Influenza Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Inhaled Nasal Influenza Vaccine Revenue Market Share by Company in 2021

Figure 21. Global Inhaled Nasal Influenza Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Inhaled Nasal Influenza Vaccine Revenue Market Share by Geographic Region in 2021

Figure 23. Global Inhaled Nasal Influenza Vaccine Sales Market Share by Region (2017-2022)

Figure 24. Global Inhaled Nasal Influenza Vaccine Revenue Market Share by Country/Region in 2021

Figure 25. Americas Inhaled Nasal Influenza Vaccine Sales 2017-2022 (K Dose)

Figure 26. Americas Inhaled Nasal Influenza Vaccine Revenue 2017-2022 ($ Millions)

Figure 27. APAC Inhaled Nasal Influenza Vaccine Sales 2017-2022 (K Dose)

Figure 28. APAC Inhaled Nasal Influenza Vaccine Revenue 2017-2022 ($ Millions)

Figure 29. Europe Inhaled Nasal Influenza Vaccine Sales 2017-2022 (K Dose)

Figure 30. Europe Inhaled Nasal Influenza Vaccine Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Inhaled Nasal Influenza Vaccine Sales 2017-2022 (K Dose)

Figure 32. Middle East & Africa Inhaled Nasal Influenza Vaccine Revenue 2017-2022 ($ Millions)

Figure 33. Americas Inhaled Nasal Influenza Vaccine Sales Market Share by Country in 2021

Figure 34. Americas Inhaled Nasal Influenza Vaccine Revenue Market Share by Country in 2021

Figure 35. United States Inhaled Nasal Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Inhaled Nasal Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Inhaled Nasal Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Inhaled Nasal Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Inhaled Nasal Influenza Vaccine Sales Market Share by Region in 2021

Figure 40. APAC Inhaled Nasal Influenza Vaccine Revenue Market Share by Regions in 2021

Figure 41. China Inhaled Nasal Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Inhaled Nasal Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Inhaled Nasal Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Inhaled Nasal Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Inhaled Nasal Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Inhaled Nasal Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Inhaled Nasal Influenza Vaccine Sales Market Share by Country in 2021

Figure 48. Europe Inhaled Nasal Influenza Vaccine Revenue Market Share by Country in 2021

Figure 49. Germany Inhaled Nasal Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Inhaled Nasal Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Inhaled Nasal Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Inhaled Nasal Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Inhaled Nasal Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Inhaled Nasal Influenza Vaccine Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Inhaled Nasal Influenza Vaccine Revenue Market Share by Country in 2021

Figure 56. Egypt Inhaled Nasal Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Inhaled Nasal Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Inhaled Nasal Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Inhaled Nasal Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Inhaled Nasal Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Inhaled Nasal Influenza Vaccine in 2021

Figure 62. Manufacturing Process Analysis of Inhaled Nasal Influenza Vaccine

Figure 63. Industry Chain Structure of Inhaled Nasal Influenza Vaccine

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles